William Richard White Gemini Therapeutics, Inc. (GMTX) insider trading activity

William Richard White is of Gemini Therapeutics, Inc. . Currently has a direct ownership of 0 shares of GMTX, which is worth approximately $0. The most recent transaction as insider was on Dec 02, 2024, when has been sold 1,957 shares (Common Stock) at a price of $64.47 per share, resulting in proceeds of $126,167. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

William Richard White Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 02 2024	SELL Open market or private sale	$126,167 $64.47 p/Share	1,957 Reduced 100.0%	0 Common Stock
Dec 02 2024	BUY Exercise of conversion of derivative security	$12,250 $6.26 p/Share	1,957 Added 50.0%	1,957 Common Stock
Nov 04 2024	SELL Open market or private sale	$415,743 $58.26 p/Share	7,136 Reduced 100.0%	0 Common Stock
Nov 04 2024	BUY Exercise of conversion of derivative security	$326,043 $45.69 p/Share	7,136 Added 50.0%	7,136 Common Stock
Nov 01 2024	SELL Open market or private sale	$9,290 $46.22 p/Share	201 Reduced 100.0%	0 Common Stock
Nov 01 2024	BUY Exercise of conversion of derivative security	$1,981 $9.86 p/Share	201 Added 50.0%	201 Common Stock
Oct 01 2024	SELL Open market or private sale	$10,226 $50.88 p/Share	201 Reduced 100.0%	0 Common Stock
Oct 01 2024	BUY Exercise of conversion of derivative security	$1,981 $9.86 p/Share	201 Added 50.0%	201 Common Stock
Sep 03 2024	SELL Open market or private sale	$99,591 $50.89 p/Share	1,957 Reduced 100.0%	0 Common Stock
Sep 03 2024	BUY Exercise of conversion of derivative security	$12,250 $6.26 p/Share	1,957 Added 50.0%	1,957 Common Stock
Aug 01 2024	SELL Open market or private sale	$8,763 $43.6 p/Share	201 Reduced 100.0%	0 Common Stock
Aug 01 2024	BUY Exercise of conversion of derivative security	$1,981 $9.86 p/Share	201 Added 50.0%	201 Common Stock
Jul 01 2024	SELL Open market or private sale	$9,207 $45.81 p/Share	201 Reduced 100.0%	0 Common Stock
Jul 01 2024	BUY Exercise of conversion of derivative security	$1,981 $9.86 p/Share	201 Added 50.0%	201 Common Stock
Jun 03 2024	SELL Open market or private sale	$70,432 $35.99 p/Share	1,957 Reduced 100.0%	0 Common Stock
Jun 03 2024	BUY Exercise of conversion of derivative security	$12,250 $6.26 p/Share	1,957 Added 50.0%	1,957 Common Stock
May 01 2024	SELL Open market or private sale	$5,792 $28.82 p/Share	201 Reduced 100.0%	0 Common Stock
May 01 2024	BUY Exercise of conversion of derivative security	$1,981 $9.86 p/Share	201 Added 50.0%	201 Common Stock
Apr 11 2024	SELL Open market or private sale	$81,894 $31.99 p/Share	2,560 Reduced 100.0%	0 Common Stock
Apr 11 2024	BUY Exercise of conversion of derivative security	$16,025 $6.26 p/Share	2,560 Added 50.0%	2,560 Common Stock
Dec 12 2023	SELL Open market or private sale	$2,132,304 $63.63 p/Share	33,511 Reduced 100.0%	0 Common Stock
Dec 12 2023	BUY Exercise of conversion of derivative security	$290,540 $8.67 p/Share	33,511 Added 50.0%	33,511 Common Stock

Also insider at

AKRO

Akero Therapeutics, Inc. Healthcare

Chief Financial Officer

VTYX

Ventyx Biosciences, Inc. Healthcare

WRW